Identify the product
Confirm the newly approved product, therapeutic area, volumes, and destination market requirements.
Global Sourcing & Procurement
Access newly FDA-approved US pharmaceutical innovations early — through a registered wholesaler with documentation-ready sourcing for international partners.
New US approvals create competitive windows for international distributors and specialty partners who can move quickly. McHade provides early access to newly FDA-approved products across priority therapeutic areas through licensed wholesaler channels.
Sourcing includes the documentation international partners need for regulatory filing and market entry — batch records, export paperwork, and supporting certificates where destination markets require them.
New approval sourcing complements tender support and named-patient programs — or stands alone when your market strategy depends on being among the first to offer a newly approved therapy.
Who it's for
What's included
How it works
A clear operating path from requirements review through documented cross-border delivery.
Confirm the newly approved product, therapeutic area, volumes, and destination market requirements.
Locate licensed US availability and assess lead times against your market entry timeline.
Procure with batch records and prepare export documentation for regulatory handoff.
Coordinate cross-border delivery with your clearing agent and local distribution partners.
Regulatory and documentation support that simplifies compliant entry into and out of the US market.
Operational quality controls with GDP-aligned storage, handling, and transportation procedures.
Full DSCSA pedigree support and traceability standards across every shipment.
Share your product requirements, volumes, and destination markets. Our team will review the scope and respond with a compliant procurement approach — turnaround depends on product complexity and market requirements.